Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity
- PMID: 11524584
- PMCID: PMC1422022
- DOI: 10.1097/00000658-200109000-00005
VSports app下载 - Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity
"V体育官网入口" Abstract
Objective: To assess the authors' experience with intraductal papillary mucinous neoplasms of the pancreas (IPMNs). VSports手机版.
Summary background data: Intraductal papillary mucinous neoplasms of the pancreas are being recognized with increasing frequency. V体育安卓版.
Methods: All patients who underwent pancreatic resection for an IPMN at the Johns Hopkins Hospital between January 1987 and December 2000 were studied. The data were compared with those of 702 concurrent patients with infiltrating ductal adenocarcinoma of the pancreas not associated with an IPMN resected by pancreaticoduodenectomy V体育ios版. .
Results: In the 13-year time period, 60 patients underwent pancreatic resection for IPMNs, with 40 patients undergoing resection in the past 3 years. Mean age at presentation was 67. 4 +/- 1. 4 years. The most common presenting symptom in patients with IPMNs was abdominal pain (59%). Most IPMNs were in the head of the pancreas or diffusely involved the gland, with 70% being resected via pancreaticoduodenectomy, 22% via total pancreatectomy, and 8% via distal pancreatectomy. Twenty-two patients (37%) had IPMNs with an associated infiltrating adenocarcinoma. In a subset of IPMNs immunohistochemically stained for the Dpc4 protein (n = 50), all of the intraductal or noninvasive components strongly expressed Dpc4, whereas 84% of associated infiltrating cancers expressed Dpc4 VSports最新版本. The 5-year survival rate for all patients with IPMNs (n = 60) was 57%. .
Conclusion: Intraductal papillary mucinous neoplasms represent a distinct clinicopathologic entity being recognized with increasing frequency. IPMNs are clinically, histologically, and genetically disparate from pancreatic ductal adenocarcinomas. The distinct clinical features, the presumably long in situ or noninvasive phase, and the good long-term survival of patients with IPMNs offer a unique opportunity for early diagnosis, curative resection, and further studies of the molecular genetics and natural history of these unusual neoplasms. V体育平台登录.
Figures
"V体育官网入口" References
-
- ReMine SG, Frey D, Rossi RL. Cystic neoplasms of the pancreas. Arch Surg 1987; 122: 443–446. - PubMed
-
- Moesinger RC, Talamini MA, Hruban RH, et al. Large cystic pancreatic neoplasms: pathology, resectability, and outcome. Ann Surg Oncol 1999; 6: 682–690. - VSports在线直播 - PubMed
-
- Compagno J, Oertal JE. Microcystic adenomas of the pancreas (glycogen-rich cystadenomas). Am J Clin Pathol 1978; 69: 289–298. - PubMed
-
- Compagno J, Oertel JE. Mucinous cystic neoplasms of the pancreas with over and latent malignancy (cystadenocarcinoma and cystadenoma). Am J Clin Pathol 1978; 69: 573–580. - PubMed
-
- Itai Y, Ohhashi K, Nagai H, et al. “Ductectatic” mucinous cystadenoma and cystadenocarcinoma of the pancreas. Radiology 1986; 161: 697–700. - "V体育平台登录" PubMed
Publication types
MeSH terms
- VSports最新版本 - Actions
- Actions (VSports在线直播)
- V体育ios版 - Actions
- V体育官网入口 - Actions
Grants and funding
LinkOut - more resources
"V体育平台登录" Full Text Sources
Medical
"V体育官网入口" Miscellaneous
